One significant advancement in endometrial cancer treatment is the combination of lenvatinib, a targeted therapy, with pembrolizumab, an immunotherapy. A recent phase 3 trial demonstrated that ...

Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial ...

The typical treatment for estrogen receptor positive (ER+) breast cancer involves surgery and years of hormone therapy that ...

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

Dave Coulier’s wife Melissa Coulier shared an update on how the Full House alum is faring amid his chemotherapy treatment for Non-Hodgkin's lymphoma.

Cancer diagnoses are expected to exceed two million in 2025, with approximately 618,120 deaths predicted, according to the ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...

Incidences for many common types of cancer have risen in recent years, with young women experiencing the brunt of the shift.